Quantitative analysis revealed a significant increase of SLIT2 levels in the grey matter of AD brains compared to non-AD control brains, accompanied by a reduction of myelinated axons (Fig. 7A-C, supplementary Table 7). Here, SLIT2 is linked to Alzheimer disease.